reference/20810388

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20810388

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, Non-P.H.S.
endingPage	97
issn	1538-8514 1535-7163
issueIdentifier	1
pageRange	87-97
publicationName	Molecular Cancer Therapeutics
startingPage	87
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_316e7ea5fde05090e7deef5af7d9b839 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e575582f1075dd1f4729555600eecef7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2f3e9cc4ecc2df497933356ee9b42ef7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b678e0875683d6d54460a561699a2030 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_021ad358888644cd2fa1862cf7d87194
bibliographicCitation	Thomas R, Sharifi N. SOD mimetics: a novel class of androgen receptor inhibitors that suppresses castration-resistant growth of prostate cancer. Mol Cancer Ther. 2012 Jan;11(1):87–97. PMID: 22172488; PMCID: PMC3256291.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b62c5f5cecb5fc56117e98e1381069e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f6011983e10c3e15e352ffbf13e7b2b
date	2012-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC3256291 https://doi.org/10.1158/1535-7163.mct-11-0540 https://pubmed.ncbi.nlm.nih.gov/22172488
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097 https://portal.issn.org/resource/ISSN/1538-8514 https://portal.issn.org/resource/ISSN/1535-7163
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	SOD Mimetics: A Novel Class of Androgen Receptor Inhibitors That Suppresses Castration-Resistant Growth of Prostate Cancer
discusses	http://id.nlm.nih.gov/mesh/M0020307 http://id.nlm.nih.gov/mesh/M0013500 http://id.nlm.nih.gov/mesh/M0042155 http://id.nlm.nih.gov/mesh/M0487221 http://id.nlm.nih.gov/mesh/M0394524 http://id.nlm.nih.gov/mesh/M0005453 http://id.nlm.nih.gov/mesh/M0545741 http://id.nlm.nih.gov/mesh/M0020832 http://id.nlm.nih.gov/mesh/M0018556 http://id.nlm.nih.gov/mesh/M0019167 http://id.nlm.nih.gov/mesh/M0255739
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D059002Q000494 http://id.nlm.nih.gov/mesh/D011944Q000378 http://id.nlm.nih.gov/mesh/D011471Q000188 http://id.nlm.nih.gov/mesh/D003497Q000494 http://id.nlm.nih.gov/mesh/D013482Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D016688 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D012333Q000378 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D008665Q000494 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D013113 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D002453Q000187
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65646 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153503 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4d10109cd13a4d21cdae0406b2417f96 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359597 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6610341 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5395

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128760372 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID248988206 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128649586 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127670457

Total number of triples: 71.